187 related articles for article (PubMed ID: 36117665)
1. Network pharmacology analysis to explore mechanism of Three Flower Tea against nonalcoholic fatty liver disease with experimental support using high-fat diet-induced rats.
Wu P; Liang S; He Y; Lv R; Yang B; Wang M; Wang C; Li Y; Song X; Sun W
Chin Herb Med; 2022 Apr; 14(2):273-282. PubMed ID: 36117665
[TBL] [Abstract][Full Text] [Related]
2. A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats.
Sun W; Liu P; Yang B; Wang M; Wang T; Sun W; Wang X; Zheng W; Song X; Li J
Phytomedicine; 2021 Jul; 88():153498. PubMed ID: 33640247
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.
Xu Z; Lin S; Gong J; Feng P; Cao Y; Li Q; Jiang Y; You Y; Tong Y; Wang P
Front Med (Lausanne); 2021; 8():681391. PubMed ID: 34179049
[No Abstract] [Full Text] [Related]
5. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
6. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.
Ma J; You D; Chen S; Fang N; Yi X; Wang Y; Lu X; Li X; Zhu M; Xue M; Tang Y; Wei X; Huang J; Zhu Y
Epigenomics; 2022 Dec; 14(23):1523-1540. PubMed ID: 36851897
[No Abstract] [Full Text] [Related]
8. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
Liu H; Xu J; Li H; Zhang L; Xu P
Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
[TBL] [Abstract][Full Text] [Related]
9. Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation
Yin G; Liang H; Sun W; Zhang S; Feng Y; Liang P; Chen S; Liu X; Pan W; Zhang F
Front Pharmacol; 2022; 13():1016745. PubMed ID: 36506575
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease].
Jiang-Dong D; Chuan-Yan L; Bing Y; Yue W; Li C; Liang F; Xiao-Bin J
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4140-4148. PubMed ID: 33164398
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation.
Xue H; Wang Y; Xiang H; Song Q; Zhang G; Wang J; Ge S
Evid Based Complement Alternat Med; 2022; 2022():5440347. PubMed ID: 36199550
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
[TBL] [Abstract][Full Text] [Related]
13. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification.
Jiang H; Mao T; Liu Y; Tan X; Sun Z; Cheng Y; Han X; Zhang Y; Wang J; Shi L; Guo Y; Li J; Han H
Front Pharmacol; 2022; 13():908128. PubMed ID: 35721171
[TBL] [Abstract][Full Text] [Related]
16. Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and
Lei S; Zhao S; Huang X; Feng Y; Li Z; Chen L; Huang P; Guan H; Zhang H; Wu Q; Chen B
Front Pharmacol; 2022; 13():967623. PubMed ID: 36172180
[No Abstract] [Full Text] [Related]
17. Network pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism.
Mao FF; Gao SS; Huang YJ; Zhou N; Feng JK; Liu ZH; Zhang YQ; Yuan LY; Wei G; Cheng SQ
Front Nutr; 2023; 10():1076569. PubMed ID: 36866057
[TBL] [Abstract][Full Text] [Related]
18. Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification.
Fu L; Wu Z; Chu Y; Chen W; Gao L; Mu S; Zhao J
Gastroenterol Res Pract; 2022; 2022():4745042. PubMed ID: 35422858
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.
Yang S; Wei Z; Luo J; Wang X; Chen G; Guan X; She Z; Liu W; Tong Y; Liu H; Wen M; Chen H; Zhu P; Li G; Wang D; Huang L; Xu S; Chen D; Zhang Q; Wei Y
Phytomedicine; 2024 Jun; 132():155834. PubMed ID: 38941818
[TBL] [Abstract][Full Text] [Related]
20. A UPLC-Q-TOF/MS and network pharmacology method to explore the mechanism of Anhua fuzhuan tea intervention in nonalcoholic fatty liver disease.
Tian FM; Yi J; Tang Y; Chen BW; Long HP; Liu YF; Ou-Yang Y; Zhang WJ; Tang RM; Liu BY
Food Funct; 2023 Apr; 14(8):3686-3700. PubMed ID: 36971300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
